Key Takeaways
- • Interpath, the UK insolvency and restructuring firm majority-owned by Bridgepoint since January, has lost four senior 'rainmaking' directors to Grant Thornton, including UK chief executive Will Wright, according to The Times.
- • Departing practitioners reportedly helped generate at least £30m of Interpath's £123m in 2025 restructuring revenues, putting tens of millions of pounds in revenue under threat.
- • Two further managing directors, Sam Birchall and Michael Leeds, are expected to join Alvarez & Marsal, which declined to comment.
- • Non-compete clauses could keep Wright, Chris Pole and Ryan Grant out of the market until mid-2028.
- • Interpath says it has more than 1,200 staff, over 150 managing directors and expects to appoint 40 new managing directors by year-end, while Grant Thornton, owned by Cinven, plans 160 new partners by the end of March.
Summary
The Times reports that the departing practitioners helped bring in at least £30m of Interpath's 2025 restructuring revenues of £123m. Total sales were £198m in the year to the end of March 2025 and grew to £250m in the 2026 financial year. The Financial Times had reported earlier this month that Wright was in talks to join Grant Thornton and that Interpath made a counter-offer to retain him. Wright had helped secure key administrations including TGI Fridays and Claire's Accessories.
The departures follow a reported leadership rift between Wright and Mark Raddan, Interpath's group chief executive, which reportedly deepened after Bridgepoint acquired a majority stake in January, including over the firm's expansion strategy. Grant Thornton, which is owned by Cinven, has been pursuing an aggressive expansion drive and expects to appoint 160 new partners by the end of March across tax, audit, restructuring and corporate finance.
Interpath said it is going from 'strength to strength' and is showing strong earnings momentum in the current financial year. It cited more than 1,200 staff, over 150 managing directors across 36 locations, and 40 expected managing director appointments by year-end. A person close to Interpath criticised reports that credit a handful of departing individuals with the work of more than 1,000 people as inflated. The Times reports there is no suggestion Interpath's future is in doubt. Grant Thornton declined to comment on individual cases, and Alvarez & Marsal declined to comment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.